This is truly a groundbreaking moment for the millions of individuals worldwide battling endometriosis. A landmark philanthropic donation of an incredible $50 million has been made to UNSW Sydney by the Ainsworth family, establishing the Ainsworth Endometriosis Research Institute (AERI). This monumental contribution, the largest of its kind globally for endometriosis research, is set to position Australia at the forefront of women's health innovation and offers unprecedented hope to the endometriosis community.
The purpose of this historic donation is clear: to accelerate breakthroughs in the diagnosis and treatment of endometriosis, ultimately striving for a cure. AERI's vision is to foster global collaboration, bringing together leading researchers, clinicians, and crucially, patients, to build a deep understanding of endometriosis biology and its pathogenesis. This comprehensive approach is designed to lead directly to improved detection, more effective management strategies, and precision-based treatments that can truly transform lives.
The potential impact on patient care and quality of life is immense. For too long, endometriosis has been misunderstood, misdiagnosed, and often inadequately treated. An institute dedicated solely to rigorous, collaborative research holds the promise of unraveling the complexities of this debilitating condition, leading to real, tangible improvements for those who suffer daily.
At Our Daughters Foundation, this news is incredibly vital to our mission. We are dedicated to funding cutting-edge research, expanding access to compassionate care, and advocating for better solutions for complex hormone-related illnesses like endometriosis. This establishment of AERI perfectly aligns with our commitment to finding answers and ensuring dignity in care for every woman and girl. It's a powerful testament to what focused investment and collaborative spirit can achieve in the fight against these often-neglected conditions.
Join us in celebrating this incredible milestone! Share this news with your networks, and consider supporting ongoing endometriosis research. Your contribution can help fuel more breakthroughs like this. Explore more about endometriosis and how you can help on our website.
UNSW Newsroom: "Landmark donation powers world-first endometriosis research institute at UNSW"
This is truly a groundbreaking moment for the millions of individuals worldwide battling endometriosis. A landmark philanthropic donation of an incredible $50 million has been made to UNSW Sydney by the Ainsworth family, establishing the Ainsworth Endometriosis Research Institute (AERI). This monumental contribution, the largest of its kind globally for endometriosis research, is set to position Australia at the forefront of women's health innovation and offers unprecedented hope to the endometriosis community.
The purpose of this historic donation is clear: to accelerate breakthroughs in the diagnosis and treatment of endometriosis, ultimately striving for a cure. AERI's vision is to foster global collaboration, bringing together leading researchers, clinicians, and crucially, patients, to build a deep understanding of endometriosis biology and its pathogenesis. This comprehensive approach is designed to lead directly to improved detection, more effective management strategies, and precision-based treatments that can truly transform lives.
The potential impact on patient care and quality of life is immense. For too long, endometriosis has been misunderstood, misdiagnosed, and often inadequately treated. An institute dedicated solely to rigorous, collaborative research holds the promise of unraveling the complexities of this debilitating condition, leading to real, tangible improvements for those who suffer daily.
At Our Daughters Foundation, this news is incredibly vital to our mission. We are dedicated to funding cutting-edge research, expanding access to compassionate care, and advocating for better solutions for complex hormone-related illnesses like endometriosis. This establishment of AERI perfectly aligns with our commitment to finding answers and ensuring dignity in care for every woman and girl. It's a powerful testament to what focused investment and collaborative spirit can achieve in the fight against these often-neglected conditions.
Join us in celebrating this incredible milestone! Share this news with your networks, and consider supporting ongoing endometriosis research. Your contribution can help fuel more breakthroughs like this. Explore more about endometriosis and how you can help on our website.
UNSW Newsroom: "Landmark donation powers world-first endometriosis research institute at UNSW"
Your support can transform lives. Every donation helps us fund research, advocate for better care, and provide essential grants to women facing debilitating conditions.
Your support can transform lives. Every donation helps us fund research, advocate for better care, and provide essential grants to women facing debilitating conditions.
How Nerves and Blood Vessels Fuel Endometriosis: Understanding Neuroangiogenesis
When we think of endometriosis, we often imagine painful periods, reproductive complications, or fatigue. But beneath these symptoms lies a deeper, more complex process—one that helps explain why this condition is so painful, why it often gets worse over time, and why standard treatments don’t always work.
That process is called neuroangiogenesis—a mouthful of a word that simply means the simultaneous growth of new nerves (neuro-) and blood vessels (-angiogenesis). And it’s changing the way experts understand and treat endometriosis.
What Is Neuroangiogenesis?
Dr. Vimee Bindra, a leading gynecologist and endometriosis specialist, puts it plainly:
“Neuroangiogenesis fuels the pain of endometriosis.”
In her article, she explains that endometriotic lesions aren’t passive—they actively create their own support systems. These lesions grow tiny blood vessels that bring in oxygen and nutrients, helping them survive even in hostile environments like the pelvis, bowel, bladder, or abdominal wall. But even more troubling, they also stimulate nerve growth—making the affected areas more sensitive and painful.
This explains why pain in endometriosis isn’t limited to menstruation. For many women, it’s constant. It flares during ovulation. It radiates into the legs or back. It worsens with movement, digestion, or intimacy.
Why? Because it’s not just inflammation—it’s nerve-driven pain. The same biological mechanisms that help our body heal after injury are being hijacked by endometriosis lesions to sustain and spread the disease.
The Science Behind It
Research supports this dual growth model:
Studies have found that vascular endothelial growth factor (VEGF), which encourages new blood vessel formation, is overproduced in endometriotic tissue.
At the same time, nerve growth factor (NGF) is elevated, helping lesions become densely innervated and hypersensitive.
In fact, some studies report that lesions have 10 to 50 times more nerve fibers than similar tissue in people without endometriosis.
This combination of angiogenesis and neurogenesis makes endometriosis uniquely painful—and uniquely difficult to treat with one-size-fits-all approaches.
Why It Matters
Pain is not just a symptom of endometriosis—it’s a sign of progression.
Neuroangiogenesis helps explain why:
Endometriosis pain doesn’t always correlate with the size of lesions.
Pain can continue even after menopause or a hysterectomy.
Hormonal treatments alone often fail to fully relieve symptoms.
Dr. Bindra emphasizes that neuroangiogenesis helps us reframe endometriosis not just as a hormonal or reproductive issue, but as a neurovascular condition—one that affects the immune system, the nervous system, and the vascular system all at once.
Understanding this has the potential to unlock better, longer-lasting solutions.
A New Direction for Treatment
This evolving science is already inspiring a shift in how endometriosis is treated:
1. Anti-Angiogenic Therapies
By targeting VEGF and other blood vessel growth signals, researchers hope to “starve” lesions and stop them from spreading. Some cancer drugs are being investigated for this purpose, including bevacizumab, which blocks VEGF.
2. Nerve-Targeted Treatments
Medications that calm overactive nerves—such as gabapentin, pregabalin, or even newer biologics aimed at NGF—may help reduce pain at its neurological source.
3. Precision Surgery
Excision surgery done by skilled specialists—especially when guided by lesion-mapping tools like the ENZIAN classification—can remove deep, infiltrating lesions and decompress trapped nerves. This type of surgery is different from ablation and requires specialized expertise, but it can offer significant relief.
As Dr. Bindra notes in her clinical work, identifying the exact location and depth of lesions—especially those invading nerves—is critical for improving surgical outcomes.
Hope on the Horizon
At Our Daughters Foundation, we believe that informed care is empowered care. And understanding neuroangiogenesis gives us all a better framework for navigating endometriosis.
It helps patients explain their pain.
It helps doctors pursue more targeted treatments.
And it helps researchers continue moving toward real, long-term solutions.
You are not imagining your pain. You are not overreacting. You are not alone.
“The more we learn about how endometriosis builds its own nerve and blood supply, the closer we get to stopping it at the source.” – Dr. Vimee Bindra
References
Dr. Vimee Bindra
“Neuroangiogenesis: How Nerves and Blood Vessels Fuel Endometriosis”
https://www.drvimeebindra.com/neuroangiogenesis-how-nerves-and-blood-vessels-fuel-endometriosis/
Dr. Vimee Bindra (LinkedIn)
Quote: “Neuroangiogenesis fuels the pain of endometriosis…”
https://www.linkedin.com/posts/dr-vimee-bindra-basu-7514765b_letstalkendo-endometriosisawarenessmonth-activity-7305270488694501381-KtCY
Tokushige N, Markham R, Russell P, Fraser IS
“Nerve fibers in peritoneal endometriosis”
Human Reproduction, 2006.
https://doi.org/10.1093/humrep/del009
Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD
“Mechanistic and therapeutic implications of angiogenesis in endometriosis”
Reproductive Sciences, 2020.
https://doi.org/10.1177/1933719119899937
Arnold J, Barcena de Arellano ML, Rüster C, et al.
“Immunologic alterations in endometriosis: current understanding and future therapeutic implications”
Journal of Clinical Medicine, 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349441/
Ferrero S, Gillott DJ, Remorgida V, et al.
“Use of antiangiogenic agents to treat endometriosis: a review”
Gynecological Endocrinology, 2010.
https://doi.org/10.3109/09513590903247814
Bindra V, et al.
“Clinical Characteristics and Locations of Lesions in Patients with Endometriosis Using ENZIAN Classification”
Journal of Obstetrics and Gynaecology of India, 2025.
https://pubmed.ncbi.nlm.nih.gov/40390882/